Enzyme immunoassay for the specific and quantitative determination of free Bevacizumab (Avastin) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Bevacizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies, even with its 5 pointmutation Fab counterpart (Ranibizumab) is excluded.
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Avastin® is a trademark of Genentech Inc./Roche.